Reuters: Health
AstraZeneca said on Thursday it has started a late-stage trial testing its diabetes drug Farxiga to reduce the risk of serious complications and organ failure in COVID-19 patients with existing heart and kidney problems.
Subscribe UsPopular Posts
|
No comments:
Post a Comment